Respiratory Inhalers market is projected to grow at a CAGR of 8.02% by 2033: Visiongain Reports Ltd
19 janv. 2023 12h06 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Respiratory Inhalers 2023-2033. It includes profiles of Respiratory Inhalers and Forecasts Market Segment by Product Type (Standard Pressurized...
Alzheimer’s Therapeutics market is projected to grow at a CAGR of 9.17% by 2032: Visiongain Reports Ltd
19 janv. 2023 11h45 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Alzheimer’s Therapeutics 2022-2032. It includes profiles of Alzheimer’s Therapeutics and Forecasts Market Segment by Drug (Donepezil, Rivastigmine,...
The Stem Cell Technologies and Applications market is projected to grow at a CAGR of 8.9% by 2032: Visiongain Reports Ltd
10 janv. 2023 06h36 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Stem Cell Technologies and Applications 2022-2032. It includes profiles of Stem Cell Technologies and Applications and Forecasts Market Segment by Type,...
Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd
09 janv. 2023 09h00 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Macular Degeneration (AMD) and Other Retinal Diseases Drugs 2022-2032. It includes profiles of Macular Degeneration (AMD) and Other Retinal Diseases...
Antiviral drugs market is projected to grow at a CAGR of 3.49% by 2032: Visiongain Reports Ltd
09 janv. 2023 06h00 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Antiviral Drugs 2022-2032. It includes profiles of Antiviral Drugs and Forecasts Market Segment by Drug Class (DNA Polymerase Inhibitors, Reverse...
Asthma & COPD Therapies market is projected to grow at a CAGR of 7.31% by 2033: Visiongain Reports Ltd
03 janv. 2023 11h56 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Asthma & COPD Therapies 2023-2033. It includes profiles of Asthma & COPD Therapies and Forecasts Market Segment by Product (Anti-inflammatory...
Global HIV and HBV Therapies market is projected to grow at a CAGR of 6.5% by 2032: Visiongain Reports Ltd
30 déc. 2022 06h00 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Global HIV and HBV Therapies Market. It includes Market Segment by Drug Class (Combination Therapies, Nucleoside and Non-nucleoside RTIs, Integrase...
Dermatology Drugs market is projected to grow at a CAGR of 6.2% by 2032: Visiongain Reports Ltd
29 déc. 2022 09h00 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Dermatology Drugs 2022-2032. It includes profiles of Dermatology Drugs and Forecasts Market Segment by Disease (Psoriasis, Dermatitis, Acne, Skin...
Antisense Oligonucleotide Therapeutics market is projected to grow at a CAGR of 13.71% by 2032: Visiongain Reports Ltd
23 déc. 2022 09h00 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Antisense Oligonucleotide Therapeutics 2022-2032. It includes profiles of Antisense Oligonucleotide Therapeutics and Forecasts Market Segment by...
OTC Drugs & Dietary Supplements market is projected to grow at a CAGR of 7.90% by 2032: Visiongain Reports Ltd
22 déc. 2022 09h00 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled OTC Drugs & Dietary Supplements 2022-2032. It includes profiles of OTC Drugs & Dietary Supplements and Forecasts Market Segment by Category...